HK1177696A1 - Pharmaceutical composition comprising solvent mixture and a vitamin derivative or analogue - Google Patents

Pharmaceutical composition comprising solvent mixture and a vitamin derivative or analogue

Info

Publication number
HK1177696A1
HK1177696A1 HK13104899.9A HK13104899A HK1177696A1 HK 1177696 A1 HK1177696 A1 HK 1177696A1 HK 13104899 A HK13104899 A HK 13104899A HK 1177696 A1 HK1177696 A1 HK 1177696A1
Authority
HK
Hong Kong
Prior art keywords
analogue
pharmaceutical composition
solvent mixture
vitamin derivative
vitamin
Prior art date
Application number
HK13104899.9A
Other languages
English (en)
Chinese (zh)
Inventor
Karsten Petersson
Original Assignee
Leo Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharma As filed Critical Leo Pharma As
Publication of HK1177696A1 publication Critical patent/HK1177696A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK13104899.9A 2009-12-22 2013-04-23 Pharmaceutical composition comprising solvent mixture and a vitamin derivative or analogue HK1177696A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK2009000264 2009-12-22
US29310810P 2010-01-07 2010-01-07
PCT/DK2010/000184 WO2011076209A2 (en) 2009-12-22 2010-12-22 Pharmaceutical composition comprising solvent mixture and a vitamin d derivative or analogue

Publications (1)

Publication Number Publication Date
HK1177696A1 true HK1177696A1 (en) 2013-08-30

Family

ID=43618136

Family Applications (1)

Application Number Title Priority Date Filing Date
HK13104899.9A HK1177696A1 (en) 2009-12-22 2013-04-23 Pharmaceutical composition comprising solvent mixture and a vitamin derivative or analogue

Country Status (15)

Country Link
US (1) US20130023501A1 (xx)
EP (1) EP2515866B1 (xx)
JP (1) JP5732471B2 (xx)
CN (1) CN102770121B (xx)
AU (1) AU2010335656B2 (xx)
BR (1) BR112012015437A2 (xx)
CA (1) CA2785254A1 (xx)
ES (1) ES2452872T3 (xx)
HK (1) HK1177696A1 (xx)
IL (1) IL220517A (xx)
MX (1) MX2012007225A (xx)
NZ (1) NZ601001A (xx)
RU (1) RU2559084C2 (xx)
WO (1) WO2011076209A2 (xx)
ZA (1) ZA201204622B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160008471A1 (en) * 2013-02-27 2016-01-14 Laurie Robert Batt Transdermal formulations
KR102486797B1 (ko) * 2016-03-09 2023-01-11 삼성전자 주식회사 전자 장치 및 전자 장치의 디스플레이 구동 방법
CN107643354B (zh) * 2016-07-22 2022-02-01 重庆华邦胜凯制药有限公司 卡泊三醇起始原料a及相关杂质的分离与测定方法
CN106265485A (zh) * 2016-08-22 2017-01-04 江苏知原药业有限公司 一种稳定性改善的卡泊三醇组合物
CN106265511A (zh) * 2016-08-22 2017-01-04 江苏知原药业有限公司 一种性能优异的卡泊三醇倍他米松自微乳制剂
CN108904445A (zh) * 2018-08-06 2018-11-30 江苏知原药业有限公司 钙泊三醇纳米悬浮液
AU2021318201A1 (en) 2020-07-28 2023-02-02 Arcutis Biotherapeutics, Inc. Topical formulation containing jak inhibitor and laureth-4

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4083974A (en) * 1977-03-07 1978-04-11 The Upjohn Company Topical steroidal anti-inflammatory preparations containing polyoxypropylene 15 stearyl ether
DE4011682A1 (de) * 1990-04-06 1991-10-10 Schering Ag 24-oxa-derivate in der vitamin d-reihe
US5194431A (en) * 1992-07-08 1993-03-16 Wisconsin Alumni Research Foundation 24-cyclopropane vitamin D derivatives
USRE39706E1 (en) * 1993-01-15 2007-06-26 Leo Pharma A/S Crystalline form of a vitamin D analogue
GB9611603D0 (en) * 1996-06-04 1996-08-07 Leo Pharm Prod Ltd Chemical compounds
US8263580B2 (en) * 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
US6267985B1 (en) * 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
EP2450043B1 (en) * 1999-04-23 2016-08-17 Leo Pharma A/S Pharmaceutical composition for dermal use to treat psoriasis comprising calcipotriol and betamethasone
EP1461044A4 (en) * 2001-12-03 2007-06-13 Novacea Inc PHARMACEUTICAL COMPOSITIONS COMPRISING ACTIVE COMPOUNDS OF VITAMIN D
MXPA06000708A (es) 2003-07-24 2006-04-19 Leo Pharma As Nuevos compuestos de aminobenzofenona.
US8741333B2 (en) * 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for treating dermatitis or psoriasis
FR2871694B1 (fr) * 2004-06-17 2008-07-04 Galderma Sa Composition pharmaceutique comprenant un onguent oleagineux et deux principes actifs solubilises
ATE455768T1 (de) 2004-12-13 2010-02-15 Leo Pharma As Triazolsubstituierte aminobenzophenonverbindungen
FR2887150B1 (fr) * 2005-06-17 2007-08-03 Galderma Res & Dev Composition pharmaceutique comprenant un elastomere organopolysiloxane et un principe actif solubilise
FR2909284B1 (fr) * 2006-11-30 2012-09-21 Galderma Sa Nouvelles compositions sous forme d'onguent sans vaseline comprenant un derive de vitamine d et eventuellement un anti-inflammatoire steroidien
RU2493149C2 (ru) 2006-12-22 2013-09-20 Лео Фарма А/С Замещенные метилфенилкетоны, пригодные для использования в качестве ингибиторов pde4
ES2478670T3 (es) 2007-02-28 2014-07-22 Leo Pharma A/S Nuevos inhibidores de la fosfodiesterasa
US7909624B2 (en) 2007-03-26 2011-03-22 Belkin International, Inc. Carabiner universal serial bus hub
JP2010524864A (ja) 2007-04-19 2010-07-22 レオ ファーマ アクティーゼルスカブ Ｓｒｃファミリーキナーゼ阻害剤
HUE063590T2 (hu) * 2007-04-25 2024-01-28 Eirgen Pharma Ltd Szabályozott felszabadulású 25-hidroxi-D-vitamin
JP2010526824A (ja) 2007-05-11 2010-08-05 ソネボーン インコーポレイテッド シリコーン類似の特性を有するワセリン
WO2010069322A1 (en) 2008-12-19 2010-06-24 Leo Pharma A/S Triazolopyridines as phosphodiesterase inhibitors for treatment of dermal diseases

Also Published As

Publication number Publication date
EP2515866A2 (en) 2012-10-31
NZ601001A (en) 2014-07-25
ZA201204622B (en) 2013-09-25
BR112012015437A2 (pt) 2016-03-15
ES2452872T3 (es) 2014-04-03
US20130023501A1 (en) 2013-01-24
WO2011076209A2 (en) 2011-06-30
MX2012007225A (es) 2012-07-30
RU2559084C2 (ru) 2015-08-10
RU2012130411A (ru) 2014-01-27
EP2515866B1 (en) 2014-02-19
WO2011076209A3 (en) 2012-02-23
JP5732471B2 (ja) 2015-06-10
CN102770121B (zh) 2014-10-15
IL220517A0 (en) 2012-08-30
AU2010335656A1 (en) 2012-07-19
CN102770121A (zh) 2012-11-07
AU2010335656B2 (en) 2015-05-07
CA2785254A1 (en) 2011-06-30
JP2013515020A (ja) 2013-05-02
IL220517A (en) 2016-08-31

Similar Documents

Publication Publication Date Title
IL275854A (en) Pharmaceutical composition and its administration
IL247260B (en) A pharmaceutical spray composition containing an analogue of vitamin D and a corticosteroid
IL217912A (en) History of 5-Amino-1-Benzimidazole-Pyrazole and Pharmaceutical Preparations Containing It
EP2360188A4 (en) HYALURONIC ACID DERIVATIVE AND PHARMACEUTICAL COMPOSITION THEREOF
HK1177696A1 (en) Pharmaceutical composition comprising solvent mixture and a vitamin derivative or analogue
IL211683A0 (en) 2-aryl-propionic acids and derivatives and pharmaceutical compositions containing them
IL206594A (en) The history of azinone-tetrahydropyridoindole and its containing pharmaceutical preparations
IL215497A0 (en) Oxadiazile derivatives and pharmaceutical compositions containing them
ZA201207839B (en) Pharmaceutical composition comprising a pyrimidineone derivative
HK1177695A1 (en) Pharmaceutical composition comprising vitamin d analogue and cosolvent- surfactant mixture d-
EP2402305A4 (en) LOXOPROFEN DERIVATIVE AND PHARMACEUTICAL PRODUCT CONTAINING SAME
HK1166633A1 (en) Indenone derivative and pharmaceutical composition comprising same
IL210446A (en) History of fibrin and medicinal preparations containing them
ZA201204620B (en) Cutaneous composition comprising vitamin d analogue and a mixture of solvent and surfactants
EP2478909A4 (en) PHARMACEUTICAL COMPOSITIONS COMPRISING BISPHOSPHONATE DERIVATIVES AND HIGH-DOSE CHOLECALCIFEROL
ZA201103347B (en) Pharmaceutical aerosol composition
IL216462A (en) Pharmaceuticals containing nitrile history and uses
HK1182093A1 (zh) 生物鹼氨基酯衍生物及其藥物組合物
EP2322505A4 (en) 1-ADAMANTYLAZETIDIN-2-ON DERIVATIVE, PREPARATION THEREOF AND PHARMACEUTICAL PREPARATION THEREWITH
ZA201101053B (en) Pharmaceutical compositions of samatotrophic hormones
GB0902648D0 (en) Pharmaceutical compounds and compositions
GB0908317D0 (en) Pharmaceutical compounds and compositions
GB0903945D0 (en) Pharmaceutical compounds and compositions
GB0908069D0 (en) Pharmaceutical compounds and compositions
GB0902651D0 (en) Pharmaceutical compounds and compositions

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20181225